Navigation Links
Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results
Date:11/9/2009

flects its current core products and does not reflect any future revenue or earnings from any product currently before the FDA awaiting approval or clearance.

In fiscal 2010, the Company will adopt Accounting Standards Codification (ASC) 470-20 (formerly FASB Staff Position No. APB 14-1), "Accounting for Convertible Debt Instruments That May Be Settled in Cash upon Conversion (Including Partial Cash Settlement)," which will increase the Company's interest expense by approximately $17 million in the first quarter and $71 million for the full year of fiscal 2010. Such amount is reflected in the EPS guidance below. However, as the additional interest expense is a non-cash item, the Company will include this as a reconciling item to arrive at non-GAAP adjusted net income and EPS.

First Quarter Fiscal 2010 (Quarter ending December 26, 2009):

    -- The Company expects first quarter fiscal 2010 revenues to be
       approximately $400 million to $405 million, comparable with the
       fourth quarter of fiscal 2009, reflecting an increase in revenues
       in the GYN Surgical and Diagnostics segments, offset by an
       anticipated decrease in the Breast Health segment, primarily related
       to the Selenia full field digital system.
    -- The Company expects EPS to be approximately $0.06 to $0.08 and
       non-GAAP adjusted EPS to be approximately $0.24 to $0.26.

Fiscal 2010 (Year ending September 25, 2010):

    -- The Company expects fiscal 2010 revenues to be approximately $1.625
       billion to $1.650 billion, driven primarily by an increase in
       revenues in the GYN Surgical and Diagnostics segments, as well as
       from Service, with continued softness in the Breast Health segment,
       primarily related to the mammography product line.

       In addition, the Company has discontinued three products that
       contributed the following revenues in Fiscal 2009:
       -- The AEG 
'/>"/>
SOURCE Hologic, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related medicine technology :

1. Three Year Analysis of Treatment Efficacy, Cosmesis, and Toxicity Support use of the Hologic Mammosite Radiation Therapy System
2. ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrigs Disease
3. Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials
4. Paclitaxel Poliglumex (OPAXIO(TM)) Added to Cisplatin and Radiation Produces 45% Pathologic Complete Remissions in Patients With Esophageal Cancer
5. Clinical and Histopathological Results Using Pollogens TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy
6. Hologic Receives CE Marking for the ThinPrep(R) Integrated Imager
7. OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer
8. Hologic Expands Healthcare Investment in Asia
9. Hologic to Host Investor Reception at RSNA 2009
10. Hologic to Present at Citis 2009 Sixth Annual Small/Mid Cap Conference
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... IRVINE, Calif. , Aug. 31, 2015 /PRNewswire/ ... business and government, where regulations are often strict ... environment is driving a demand for professionals who ... interpret these regulations across a product lifecycle and ... organization. The University of California, Irvine Extension ...
(Date:8/31/2015)... FLINT, Mich. , Aug. 31, 2015  Diplomat Pharmacy, ... pharmacy, has announced that Phil Hagerman , Chairman & ... four upcoming investor conferences. Mr. Hagerman and ... 2015 Healthcare Conference in Boston on ... Mr. Hagerman and Mr. Whelan are also scheduled to participate ...
(Date:8/31/2015)... , Aug. 31, 2015  Qualcomm Incorporated ... subsidiary, Qualcomm Life, Inc., is collaborating ... chronic care management solutions powered by Qualcomm Life,s ... Platform to enable continuous care, informed interventions and ... announced at Qualcomm Life,s annual Connect 2015 ...
Breaking Medicine Technology:UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3Diplomat to Participate in Upcoming Investor Conferences 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5
... 2011 Reportlinker.com announces that a new market research ... Global Injectable Drug Delivery Market (2010 - 2015) ... KEY TAKE AWAYS * To ... its various sub-segments with respect to types of systems, ...
... Reportlinker.com announces that a new market research report ... European Markets for Minimally Invasive Spinal Devices ... The European minimally invasive spinal implant ... Rapid growth of the MIS interbody and MIS ...
Cached Medicine Technology:Reportlinker Adds Global Injectable Drug Delivery Market (2010 - 2015) 2Reportlinker Adds Global Injectable Drug Delivery Market (2010 - 2015) 3Reportlinker Adds European Markets for Minimally Invasive Spinal Devices 2011 2
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... September 9, 2015 from 5:00 to 8:00 pm at the Marriott Indianapolis Downtown, ... groups with career opportunities will be attending from across the country. All specialties ...
(Date:9/1/2015)... ... September 01, 2015 , ... Dr. Trace Curry successfully placed one ... In the last month the FDA has approved two intra-gastric balloons, the ... procedures represent the first incisionless, reversible, weight loss procedures available to Americans. ...
(Date:9/1/2015)... ... September 01, 2015 , ... Elizabeth Callahan, MD, founder and medical director ... the area to offer RADIESSE® filler treatment for volume loss in the hands. RADIESSE ... and veins in the hands, delivering smooth, natural-looking results that can last up to ...
(Date:9/1/2015)... , ... September 01, 2015 , ... September is Baby ... manufacturers use safety labels and stickers to keep little ones' safety top of mind ... Safety Month has a particular focus. According to the JPMA's Baby Safety Zone website, ...
(Date:8/31/2015)... ... September 01, 2015 , ... The PT Outcomes Registry is an organized ... physical therapy patients. The Registry is being developed by the American Physical Therapy Association ... happy to be selected to contribute FOTO Outcomes measures as one of the primary ...
Breaking Medicine News(10 mins):Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 3Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 4Health News:Dr. Trace Curry Performs First ORBERA™ Intra-gastric Balloon in Ohio at JourneyLite, a New Incisionless Option For The Treatment of Obesity 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 3Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 2Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 3Health News:FOTO Selected as Official Registry Partner with Physical Therapy Outcomes Registry 2
... massive, unfunded public employee retirement benefits, Full Disclosure Network® is re-releasing ... officials and finance experts, including Mr. B. Scott Minerd, CEO Guggenheim ... Featured here is a six minute video preview available for ... ...
... Cinegon lenses on the Space Shuttle delivered high-resolution video , ... ... Optics, a worldwide market leader in high-quality lenses for industrial applications, ... were selected by NASA to play an important role in the ...
... You Can Rest , ... New York (Vocus) May 28, 2009 -- There is a ... even know. Snoring is more than an annoyance. It,s both a ... dentists of Snoring Isn,t Sexy® have united to promote the awareness ...
... in Earlier, Detection of Disease ... /PRNewswire-FirstCall/ - MDS Nordion, a leading global provider ... medicine, today announced the opening of a facility ... (Fluorodeoxyglucose), a radiopharmaceutical used in positron emission tomography ...
... May 27 Kindred Healthcare (NYSE: KND ) ... their families who have served our country through military service. ... gave the perception that we do not respect the flag ... Kindred Healthcare nor Kindred Hospital Mansfield to restrict the rights ...
... Balfour Beatty Construction and Sleep Experts have ... Greater Dallas Business Ethics Awards. Two area medical ... Medical Center, L.L.P., were among the nine finalists.The ... Fuel Distributors, L.P., Aspire, Cadence McShane Construction Company ...
Cached Medicine News:Health News:California Public Pension Crisis: The Ticking Time Bomb, a Full Disclosure Network Cable TV Series 2Health News:Hubble Space Telescope Servicing In Orbit Monitored By Three Schneider Lenses 2Health News:Hubble Space Telescope Servicing In Orbit Monitored By Three Schneider Lenses 3Health News:Snoring Isn't Sexy Launches Public Awareness Campaign 2Health News:MDS Nordion Opens New Radiopharmaceutical Production Facility in Belgium 2Health News:Kindred Healthcare Supports the Flag and the Sacrifices it Represents 2Health News:Medical Facilities Among Finalists for Greater Dallas Business Ethics Awards 2
The Equator Convective Warmer incorporates LEVEL 1's unique, patented, temperature control technology to ensure delivery of the desired therapy to the patient....
The QuickVue Advance® G. vaginalis test is an enzyme activity test for use in the detection of Gardnerella vaginalis Proline IminoPeptidase(PIP) activity in vaginal fluid specimens from women su...
The Micro-Temp® II safely and consistently delivers a therapeutic level of localized heat using a pump, connecting hose and localized temperature therapy pad....
The Osom® Bvblue Test detects elevated vaginal fluid sialidase activity, an enzyme produced by bacterial pathogens associated with Bacterial Vaginosis including Gardnerella, Bacteroides, Prevote...
Medicine Products: